MedTrace Logo

Screening Protocol for Research Participants

NCT01010620 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 523

Last updated 2019-08-19

No results posted yet for this study

Summary

The Screening Protocol is a system devised to evaluate potential research participants for National Institute on Drug Abuse/Maryland Psychiatric Research Center (NIDA/MPRC) studies.

Conditions

Interventions

BEHAVIORAL

Various Screening psychiatric and medical assessments

Possibly blood draws, urine samples, toxicology screens, computer-based and written psychological, psychiatric, and behavioral questionnaires and assessments.

Sponsors & Collaborators

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Deanna L Kelly, Pharm.D., BCPP · University of Maryland, College Park

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2019-06-01
Completion
2019-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01010620 on ClinicalTrials.gov